HIV/AIDS

Treatment Adherence

Pharmacy Education

AACP

ACCP

APhA

ASHP

Rho Chi

Phi Delta Chi

Daftary MN, Goolsby T, Farhat F. An Update in the Management of Hepatitis B/HIV Co-Infection. Journal of Pharmacy Practice 2006; 19(1): 31-36

Reddy R, Daftary MN, Delapenha RD, Dutta AP, Oliver J, Frederick W. Avascular Necrosis and Protease Inhibitor Therapy: 3 Cases. Journal of the National Medical Association 2005; 97(11): 1543 -1546.

Dutta AP, Daftary MN, Oke F, Mims B, Hailemeskel B, Sansgiry S. Geriatric Education in U.S. Schools of Pharmacy: A Snap Shot. Consultant Pharmacist 2005; 20(1): 45-51.

Drew R, Aeschlimann J, Allen GP, Bearden D, Brock J, Carver P, Clay P, Daftary MN, Destache C, Gelone S, Grim SA, Hall RG, Herring T, Jaso T, Johnson JW, Kishel J, Lee J, McCoy C, Mohr J, Pasquale T, Segarra-Newnham M, Suda KJ, Villman M,Yang K. Key References on Infectious Diseases Pharmacotherapy. Pharmacotherapy 2004; 24(11): 1586-1593.

Hailemeskel B, Daftary MN, Ayuk-Egbe P, Bernard D , AkiyodeO, Dutta A, Bullard W, Olusanya O, Bwayo S, Keeys C, Kalejaiye B. Selected Non-Approved Use of Recombinant Human Erythropoietin.. Advances in Pharmacy 2004 (Summer), Volume 2, Number 3: 280-288.

Bullard W, Hailemeskel B, Ayuk-Egbe P, Daftary M, Akiyode O, Dutta A, Bernard D, Belrhiti S, Eze G, Keeys C. Selected Non-Approved Use of Recombinant Human Erythropoietin, Part 1 of 2. Advances in Pharmacy 2004 (Spring), Volume 2, Issue 2: 147-155.

Daftary, Monika N (2003). Adefovir (Hepsera) for chronic hepatitis B infection. Am Fam Physician 2003 (Dec 15); 68(12): 2429-30.

Daftary MN, Lee E, Dutta AP, Xue Z, Olagundoye A. Patient Willingness to Pay for Cognitive Pharmacy Services in Ambulatory Care Settings. Journal of Pharmacy Practice and Research 2003 (December); 33: 265-7.

Dutta A, Daftary MN, Ayuk-Egbe P, Kang H. State of CAM Education in US Schools of Pharmacy: Results of a National Survey. Journal of the American Pharmaceutical Association 2003;43(1):81-83.